Supernus Pharmaceuticals SUPN
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$21.86M (11 inflow days, 9 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 22.5% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 7.14% to 7.93% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Jack Khattar | Individual/Insider | 2026/Q3 | +3,413,555 | 1.6% |
| Westfield Capital Management Company, L.P. | Mutual Fund | 2026/Q3 | +2,853,945 | 1.9% |
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +1,999,416 | 1.7% |
| Westchester Capital Management, LLC | Mutual Fund | 2026/Q3 | +775,856 | 0.4% |
| Danske Capital AS (Estonia) | Mutual Fund | 2026/Q3 | +524,489 | 0.5% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +362,126 | 0.2% |
| Morgan Stanley | Public Company | 2026/Q3 | +246,586 | 1.8% |
| Public Sector Pension Investment Board | Government Pension Fund | 2026/Q3 | +232,531 | 0.3% |
| BNP Paribas Financial Markets SNC | Private Company | 2026/Q3 | +232,315 | 0.2% |
| Two Seas Capital LP | Hedge Fund | 2026/Q3 | +191,579 | 1.8% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +4,244,706 | 3.1% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +1,155,696 | 0.6% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +913,150 | 2.0% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +816,160 | 0.5% |
| Armistice Capital LLC | Hedge Fund | 2026/Q3 | +750,854 | 4.6% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 11 Aug 2026 | Jack Khattar | Founder, President, CEO, Secretary & Director | Derivative Exercise and Sale | -12,642 | $46.57 | 2,216,451 |
| 11 Aug 2026 | Jack Khattar | Founder, President, CEO, Secretary & Director | Derivative Exercise and Retained | +17,207 | – | 2,216,451 |
| 11 Aug 2026 | Timothy Dec | Senior Vice President | Derivative Exercise and Sale | -604 | $46.57 | 9,129 |
| 11 Aug 2026 | Timothy Dec | Senior Vice President | Derivative Exercise and Retained | +646 | – | 9,129 |
| 11 Aug 2026 | Padmanabh Bhatt | Chief Scientific Officer & Senior VP of Intellectual Property | Derivative Exercise and Sale | -1,158 | $46.57 | 18,637 |
| 11 Aug 2026 | Padmanabh Bhatt | Chief Scientific Officer & Senior VP of Intellectual Property | Derivative Exercise and Retained | +1,342 | – | 18,637 |
| 11 Aug 2026 | Jonathan Rubin | Senior VP of Research & Development and Chief Medical Officer | Derivative Exercise and Sale | -363 | $46.57 | 13,979 |
| 11 Aug 2026 | Jonathan Rubin | Senior VP of Research & Development and Chief Medical Officer | Derivative Exercise and Retained | +387 | – | 13,979 |
| 11 Aug 2026 | Frank Mottola | Senior VP & Chief Technology Operations Officer | Derivative Exercise and Sale | -797 | $46.57 | 19,544 |
| 11 Aug 2026 | Frank Mottola | Senior VP & Chief Technology Operations Officer | Derivative Exercise and Retained | +853 | – | 19,544 |
| 28 Jul 2026 | Jack Khattar | Founder, President, CEO, Secretary & Director | Other Derivative Acquisition | +29,849 | – | 29,849 |
| 28 Jul 2026 | Timothy Dec | Senior Vice President | Other Derivative Acquisition | +1,250 | – | 1,250 |
| 28 Jul 2026 | Padmanabh Bhatt | Chief Scientific Officer & Senior VP of Intellectual Property | Other Derivative Acquisition | +2,500 | – | 2,500 |
| 28 Jul 2026 | Jonathan Rubin | Senior VP of Research & Development and Chief Medical Officer | Other Derivative Acquisition | +750 | – | 750 |
| 28 Jul 2026 | Frank Mottola | Senior VP & Chief Technology Operations Officer | Other Derivative Acquisition | +1,650 | – | 1,650 |
| 17 Mar 2026 | Padmanabh Bhatt | Chief Scientific Officer & Senior VP of Intellectual Property | Derivative Exercise and Sale | -107,250 | $50.73 | 17,044 |
| 16 Mar 2026 | Padmanabh Bhatt | Chief Scientific Officer & Senior VP of Intellectual Property | Intent to Sell (Form 144) | -57,250 | $50.21 | – |
| 15 Mar 2026 | Padmanabh Bhatt | Chief Scientific Officer & Senior VP of Intellectual Property | Intent to Sell (Form 144) | -50,000 | $49.91 | – |
| 12 Mar 2026 | Jack Khattar | Founder, President, CEO, Secretary & Director | Other Acquisition | +12,500 | – | 2,199,244 |
| 12 Mar 2026 | Jack Khattar | Founder, President, CEO, Secretary & Director | Other Disposition | -12,500 | – | 2,199,244 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 4,619,509 | 7.9% | 3.4 |
| 15 Oct 2026 | 4,043,677 | 6.9% | 4.9 |
| 30 Sep 2026 | 4,985,929 | 8.6% | 7.4 |
| 15 Sep 2026 | 4,989,421 | 8.6% | 8.7 |
| 31 Aug 2026 | 4,671,860 | 8.0% | 8.3 |
| 14 Aug 2026 | 4,147,629 | 7.1% | 2.8 |
No comments yet — be the first to weigh in on SUPN.
Sign in to join the discussion.